Malvern, PA - Originally introduced at the 2008 Society of Nuclear Medicine Annual Meeting, June 14-18, in New Orleans, IQ/SPECT is Siemens newest Symbia® feature that enables a comprehensive cardiac evaluation including perfusion, attenuation correction and calcium scoring in just five minutes.

IQ/SPECT technology is achieved with SMARTZOOM collimators that magnify the heart while imaging the rest of the torso under traditional conditions. Combining this cardio-centric orbit acquisition technique with fast, 3D iterative reconstruction enables more confident diagnoses and improved patient comfort, enhancing image quality, speed, productivity and throughput.

IQ/SPECT is 510k-cleared and commercially available on all Symbia S and T systems, and is field upgradeable for any existing systems.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion, orders of €10.27 billion, and group profit of €1.32 billion. Further information can be found by visiting http://www.siemens.com/healthcare.

More HCB News